Advertisement

Topics

Sensile Medical to be acquired by Gerresheimer for up to $409M

07:36 EDT 13 Jul 2018 | SmartBrief

An agreement has been reached by Germany-based Gerresheimer to pay up to $409 million, which includes milestone-based payment -More

Original Article: Sensile Medical to be acquired by Gerresheimer for up to $409M

NEXT ARTICLE

More From BioPortfolio on "Sensile Medical to be acquired by Gerresheimer for up to $409M"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...